Beatson Scientist wins Activate Challenge
04th February 2020
The Cancer Research UK Beatson Institute hosted the CRUK Activate Challenge Final, together with our partners Converge who run various business challenges open to young entrepreneurs in Scotland. The Activate Challenge is part of an initiative to encourage a culture of entrepreneurship among CRUK's researchers.
Glasgow scientist who survived cancer launches World Cancer Day in Scotland
29th January 2020
A GLASGOW cancer scientist who himself survived the disease as a child has been chosen as the face of a new campaign designed to save lives.
Joining forces with Novartis to advance novel cancer therapeutics
26th October 2019
The Beatson Drug Discovery Unit (DDU) has recently entered into a collaboration with Novartis to progress its ground-breaking work on the development of KRAS inhibitors.
Payam Gammage joins the Beatson Institute
14th August 2019
The Beatson Institute is delighted to welcome Dr Payam Gammage as a Junior Group Leader. Payam joins the Institute from the MRC Mitochondrial Biology Unit, University of Cambridge where he developed methods to manipulate mitochondrial DNA and applied them to study mitochondrial dysfunction in cell and animal models.
Julia Cordero awarded Pioneer Award
23rd May 2019
The Institute of Cancer Science’s Dr Julia Cordero has been awarded a Cancer Research UK Pioneer Award. These awards fund innovative, higher-risk ideas that could revolutionise our understanding of cancer.
Making more proteins for drug discovery research
1st May 2019
Beatson Institute researchers have unravelled a new way to maximise the production of important cancer-related proteins for study in the laboratory. This work, led by Dr Chris Gray of the Institute’s Drug Discovery Programme, has demonstrated that subtle changes to the genetic instructions given to bacterial protein factories can dramatically improve the recovery of high-quality proteins.
The work has been published in PLoS One.
These findings refine and optimise current recombinant technologies, used globally for the production of proteins for the laboratory and the clinic. As a consequence of this discovery, larger amounts of key reagents can be delivered to our drug discovery programmes, accelerating the development of new therapies.
Click here to read more about the Drug Discovery Programme.
Ed Roberts joins the Beatson Institute
17th April 2019
The Beatson Institute is very pleased to welcome Dr Ed Roberts as a new Junior Group Leader. Ed joins the Institute from UCSF, where he studied a class of immune cell called migratory dendritic cells and the role they play in the body’s response to cancer, and specifically how these cells communicate with the lymph nodes.
Two recent major projects
17th April 2019
Beatson Institue Director Owen Sansom has been interviewed by Bowel Cancer UK about an exciting project he is leading that aims to improve outcomes for bowel cancer patients. Click here to read the interview.
Another major project Owen is involved in - which aims to find out why different gene faults only cause cancer in particular parts of the body - has been covered by Cancer Research UK's blog.
Johan Vande Voorde 'Walking All Over Cancer'
11th April 2019
In March, Beatson scientist Dr Johan Vande Voorde called on Scots to walk 10,000 steps a day to help raise money for Cancer Research UK's Walk All Over Cancer campaign. Johan and his loyal sidekick Sookie were chosen to launch the fundraising challenge in Scotland.
Crispin Miller joins the Beatson Institute
20th March 2019
The Beatson Institute would like to extend a warm welcome to Dr Crispin Miller, who has just started as our Head of Bioinformatics. Crispin joins us from Manchester, where he was senior group leader of the RNA Biology group at the Cancer Research UK Manchester Institute.
Beatson researchers to receive almost £1.8 million CRUK Grand Challenge funding
23rd January 2019
Beatson researchers are set to receive almost £1.8 million over the next five years as part of a £19 million investment in a global project to investigate why some cancers are specific to certain tissues and not others.
Exposing liver cancer
9th January 2019
9th January 2019Dr Tom Bird has been working with the University of Edinburgh's Centre for Statistics to develop better ways of detecting early forms of liver cancer. Click here to read more.
Click here to read more about Tom's research group.
Improving cell culture media
7th January 2019
Beatson Institute researchers led by Dr Saverio Tardito have been investigating the difference that using traditional media vs a homemade one that more closely mimics physiological conditions can make to the outcome of experiments. The work has been published in Science Advances: Improving the metabolic fidelity of cancer models with a physiological cell culture medium. The research has been covered in an article in The Atlantic: Scientists Have Been Studying Cancers in a Very Strange Way for Decades and also in Cancer Research UK's blog: Cell culture shock – a scientist’s hunt for the perfect cocktail.
Click here to read more about Saverio's research group.
